John C. Martin
2012 - Gilead Sciences
In 2012, John C. Martin earned a total compensation of $15.3M as Chairman and Chief Executive Officer at Gilead Sciences, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,375,000 |
|---|---|
| Option Awards | $5,433,431 |
| Salary | $1,494,214 |
| Stock Awards | $4,947,127 |
| Other | $7,500 |
| Total | $15,257,272 |
Martin received $5.4M in option awards, accounting for 36% of the total pay in 2012.
Martin also received $3.4M in non-equity incentive plan, $1.5M in salary, $4.9M in stock awards and $7.5K in other compensation.
Rankings
In 2012, John C. Martin's compensation ranked 179th out of 11,487 executives tracked by ExecPay. In other words, Martin earned more than 98.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 179 out of 11,487 | 98th |
Division Manufacturing | 70 out of 4,252 | 98th |
Major group Chemicals And Allied Products | 14 out of 1,200 | 99th |
Industry group Drugs | 9 out of 922 | 99th |
Industry Biological Products, Except Diagnostic Substances | 2 out of 165 | 99th |
Source: SEC filing on March 27, 2015.
Martin's colleagues
We found four more compensation records of executives who worked with John C. Martin at Gilead Sciences in 2012.